Back
MediPharm Labs Vs. Lexaria Bioscience Industry Stock Comparison
Sell
47
MEDIF
MediPharm Labs
Last Price:
0.05
Seasonality Move:
-2.25%
Sell
27
LEXX
Lexaria Bioscience
Last Price:
2.25
Seasonality Move:
17.67%
Sell
47
MediPharm Labs (MEDIF)
is a Sell
Is MediPharm Labs a Buy, Sell or Hold?
- The current MediPharm Labs [MEDIF] share price is $0.05. The Score for MEDIF is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
- MEDIF is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
27
Lexaria Bioscience (LEXX)
is a Sell
Is Lexaria Bioscience a Buy, Sell or Hold?
- The current Lexaria Bioscience [LEXX] share price is $2.30. The Score for LEXX is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
- LEXX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
MEDIF Stock Price Chart
What is MediPharm Labs's stock price today?
-
The MediPharm Labs share price today is $0.05
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MEDIF is experiencing selling pressure, which indicates risk of future bearish movement.
LEXX Stock Price Chart
What is Lexaria Bioscience's stock price today?
-
The Lexaria Bioscience share price today is $2.30
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and LEXX is experiencing slight buying pressure.
MEDIF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0 | Sell |
| Relative Strength Index (14 RSI): | 52.33 | Buy |
| Chaikin Money Flow: | 27645 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.05 - 0.05) | Buy |
| Bollinger Bands (100): | (0.05 - 0.05) | Buy |
LEXX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.2 | Sell |
| Relative Strength Index (14 RSI): | 35.86 | Sell |
| Chaikin Money Flow: | 153358 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.29 - 2.91) | Sell |
| Bollinger Bands (100): | (2.59 - 3.41) | Sell |
MEDIF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.05 | Buy |
| 20-day SMA: | 0.05 | Buy |
| 50-day SMA: | 0.05 | Buy |
| 200-day SMA: | 0.05 | Sell |
| 8-day EMA: | 0.05 | Buy |
| 20-day EMA: | 0.05 | Buy |
| 50-day EMA: | 0.05 | Buy |
| 200-day EMA: | 0.05 | Sell |
LEXX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.29 | Buy |
| 20-day SMA: | 2.48 | Sell |
| 50-day SMA: | 2.93 | Sell |
| 200-day SMA: | 3.01 | Sell |
| 8-day EMA: | 2.32 | Sell |
| 20-day EMA: | 2.48 | Sell |
| 50-day EMA: | 2.77 | Sell |
| 200-day EMA: | 2.79 | Sell |
MediPharm Labs Earnings Growth & MEDIF Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Lexaria Bioscience Earnings Growth & LEXX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.43 per share, and an increase next year of $0.09 per share.
MediPharm Labs Technical Analysis
| Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Lexaria Bioscience Technical Analysis
| Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||